nci logo
NIH
U.S. National Institutes of Health National Cancer Institute

SEER Inquiry System - Home


Welcome to the SEER Inquiry System (SINQ). SINQ is a collection of questions that cancer registrars have had while coding cancer cases. Click Search to look for specific questions or to select questions for a Report.
Recent Questions 1 to 10 of 1213    Next 10 >    Last >>
Add to Report ID Question Status Last Updated
20091104 MP/H Rules/Histology--Esophagus: Biopsy of esophagus - path report states "adenocarcinoma, intestinal type". There is no evidence of a gastric tumor in scans or EDG. There is a rule for colon to disregard "intestinal type" and code to adenocarcinoma (8140) but no rule for esophagus. How should histology for this esophageal case be coded? Final Oct 14 2009
20091103 Reportability/Ambiguous Terminology--Prostate: Text from prostate biopsy states "highly suspicious for but not diagnostic of adenocarcinoma suggest another biopsy" Is this case reportable? Final Oct 14 2009
20091102 MP/H Rules/Histology--Thyroid: What is the correct histology for these thyroid tumors? In each case, the path report reads, "Papillary sclerosing carcinoma." In one case, the results are in CAP protocol format and next to 'Encapsulation of tumor' it says 'No.' In the other case, it is not in CAP format, but the microscopic description says, 'encapsulation of tumor - no.' Is the correct code 8350? Final Oct 01 2009
20091100 MP/H Rules/Histology--Melanoma: Path: Melanoma in situ, lentiginous type, skin rt lower leg. Is this the same as acral lentiginous melanoma (8744)? To code to 8744, do we specifically have to see the word "acral" lentiginous melanoma? Please see discussion. Final Oct 01 2009
20091098 MP/H Rules/Histology: Final diagnosis from a partial vulvectomy says, "vulvar intraepithelial neoplasia III, basaloid type." Is this VIN III (8077/2) or basaloid squamous cell carcinoma (8083 and change the bevavior code from 3 to 2)? Which Histology rule applies? It seems to me that H4 and H6 both lead to 8083. Final Oct 14 2009
20091097 Histology--Lymphoma: If two different histologies of the same type of Lymphoma (two different histologies for NHL: DLBCL 9680/3 + Mantle Cell Lymphoma 9673/3) occur in the same time in different lymph nodes, how do we code the histology, and what would be the sequence number if this would be considered as multiple primaries? Please see discussion. Final Oct 14 2009
20091096 MP/H Rules/Multiple primaries--Breast: When an in situ diagnosis is followed by an invasive diagnosis in the same breast 1.5 years later, is it a new primary? See discussion. Final Oct 01 2009
20091095 CS Site Specific Factor--Prostate: Please clarify how SEER registries should use code 40 for site-specific factor 3 on prostate cases. Please see discussion. Final Oct 09 2009
20091094 Reportability: Are squamous cell carcinomas arising in a condyloma of the rectum reportable or should we assume that the site is skin of anus or perianal and not reportable? Final Aug 27 2009
20091093 Race--How and when is Appendix D – Race and Nationality Descriptions from the 2000 Census and Bureau of Vital Statistics to be used? Please see discussion. Final Aug 10 2009
Next 10 >